Related Experiment Videos
Siblings with chromosome mosaicism, microcephaly, and growth retardation: the phenotypic expression of a human
J L Tolmie1, E Boyd, P Batstone
1Duncan Guthrie Institute of Medical Genetics, Yorkhill Hospitals, Glasgow, UK.
Human Genetics
|October 1, 1988
Abstract:
We report male and female siblings with extreme microcephaly and mental retardation, growth retardation, and multiple chromosome mosaicism. Mental retardation associated with chromosome mosaicism does not always carry a low recurrence risk.
Insights
Genetic counseling is crucial for families with chromosome mosaicism, as it can lead to severe developmental issues like microcephaly and intellectual disability. This condition may carry a higher recurrence risk than previously assumed.
Area of Science:
- Genetics
- Developmental Biology
- Clinical Medicine
Background:
- Chromosome mosaicism, a condition where cells have different chromosomal compositions, is often associated with genetic disorders.
- Understanding the inheritance patterns and recurrence risks of chromosomal abnormalities is vital for genetic counseling and family planning.
Observation:
- This study details male and female siblings presenting with severe phenotypes.
- Key features included extreme microcephaly (abnormally small head size), significant growth retardation, and profound intellectual disability.
- Multiple chromosomal mosaicism was identified as a common underlying genetic factor in both siblings.
Findings:
- The siblings exhibited a complex genetic condition characterized by multiple chromosome mosaicism.
- The observed intellectual disability and growth retardation were severe, indicating a significant impact on development.
- The presence of multiple chromosome mosaicism in siblings suggests a potential inherited or de novo genetic event.
Implications:
- The findings challenge the assumption of a universally low recurrence risk for intellectual disability linked to chromosome mosaicism.
- This case highlights the importance of thorough genetic evaluation in families with unexplained developmental delays and dysmorphic features.
- Accurate recurrence risk assessment is essential for informed genetic counseling and reproductive decision-making in affected families.